Herceptin’s US sales were just over $2.9 billion last year, and globally they were nearly $6.8 billion, and it has been off-patent in Europe since 2014.

The FDA has approved a new biosimilar of Roche’s breast cancer drug Herceptin, from Samsung Bioepis and Merck & Co, ahead of the original drug’s US patent expiry in June.

Under this agreement, SHA will pay Sh40,000 per session, including the administration of the Herceptin drug, reducing the cost by Sh80,000.

CHICAGO — Second-line trastuzumab deruxtecan-nxki significantly extended OS compared with paclitaxel plus ramucirumab for patients with advanced gastric cancers previously treated with ...

Health Minister Jonathan Coleman has conceded the Government was wrong to override Pharmac and fund breast cancer drug Herceptin in 2008, as it comes under continued pressure to step in over "game ...

Herceptin SC contains the active ingredient trastuzumab. Herceptin SC belongs to a group of medicines known as anti-neoplastic (or anti-cancer) agents. There are many different classes of anti ...

The NHS's drugs watchdog says people with early stage breast cancer should be able to get the drug Herceptin. The draft guidance from the National Institute for Health and Clinical Excellence (NICE) ...

The maker of breast cancer drug Herceptin has applied for a licence for it to be used to treat the early stages of the disease. Manufacturer Roche claims its research shows the drug halves the risk of ...

For more than a decade, the first-line standard of care for locally advanced or metastatic HER2-positive breast cancer has been a taxane given with trastuzumab (Herceptin; Genentech) and ...

Ann Marie Rogers recently won a landmark victory to make the breast cancer drug Herceptin more widely available. Here, she explains what drove her. But others are asking if the treatment really ...

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.